TLR4 and cancer: Even though the underlying mechanism is not yet fully elucidated, elevated expression of upstream components of the Toll pathway, such as PGRP-SA, are suggested to contribute to local Toll pathway activation in malignant tumor cells (Dillard et al., 2024).